View Item 

Show simple item record

Hypertension in African Americans Aged 60 to 79 Years: Statement From the International Society of Hypertension in Blacks
dc.contributor.authorEgan, Brent M.en_US
dc.contributor.authorBland, Veita J.en_US
dc.contributor.authorBrown, Angela L.en_US
dc.contributor.authorFerdinand, Keith C.en_US
dc.contributor.authorHernandez, German T.en_US
dc.contributor.authorJamerson, Kenneth A.en_US
dc.contributor.authorJohnson, Wallace R.en_US
dc.contributor.authorKountz, David S.en_US
dc.contributor.authorLi, Jiexiangen_US
dc.contributor.authorOsei, Kwameen_US
dc.contributor.authorReed, James W.en_US
dc.contributor.authorSaunders, Elijahen_US
dc.date.accessioned2015-05-04T20:35:48Z
dc.date.available2016-05-10T20:26:28Zen
dc.date.issued2015-04en_US
dc.identifier.citationEgan, Brent M.; Bland, Veita J.; Brown, Angela L.; Ferdinand, Keith C.; Hernandez, German T.; Jamerson, Kenneth A.; Johnson, Wallace R.; Kountz, David S.; Li, Jiexiang; Osei, Kwame; Reed, James W.; Saunders, Elijah (2015). "Hypertension in African Americans Aged 60 to 79 Years: Statement From the International Society of Hypertension in Blacks." The Journal of Clinical Hypertension 17(4): 252-259.en_US
dc.identifier.issn1524-6175en_US
dc.identifier.issn1751-7176en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/111078
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherYearbook Medical Publishersen_US
dc.titleHypertension in African Americans Aged 60 to 79 Years: Statement From the International Society of Hypertension in Blacksen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/111078/1/jch12511.pdf
dc.identifier.doi10.1111/jch.12511en_US
dc.identifier.sourceThe Journal of Clinical Hypertensionen_US
dc.identifier.citedreferenceMancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34: 2159 – 2219.en_US
dc.identifier.citedreferenceOgihara T, Saruta T, Rakugi H, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension Study. Hypertension. 2010; 56: 196 – 202.en_US
dc.identifier.citedreferenceLiu L, Zhang Y, Liu G, et al. The Felodipine Event Reduction (FEVER) study: a randomized long‐term placebo‐controlled trial in Chinese hypertensive patients. J Hypertens. 2005; 23: 2157 – 2172.en_US
dc.identifier.citedreferenceVerdecchia P, Staessen JA, Angeli F, et al. Usual versus tight control of systolic blood pressure in non‐diabetic patients with hypertension (Cardio‐Sis): an open‐label randomised trial. Lancet. 2009; 374: 525 – 533.en_US
dc.identifier.citedreferenceThe SPS3 Study Group. Blood‐pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013; 382: 507 – 515.en_US
dc.identifier.citedreferencePROGRESS Collaborative Group. Randomised trial of a perindopril‐based blood‐pressure‐lowering regimen among 6109 individuals with previous stroke or transient ischaemic attack. Lancet. 2001; 358: 1033 – 1041.en_US
dc.identifier.citedreferenceGo AS, Bauman MA, Coleman King SA, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension. 2013; http://hyper.ahajournals.org/content/early/2013/11/14/HYP.0000000000000003.citation. Accessed July 23, 2014.en_US
dc.identifier.citedreferenceWeber MA, Schiffrin EL, White SB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014; 16: 14 – 26.en_US
dc.identifier.citedreferenceNational Institute for Health and Care Excellence. NICE quality standards [QS28] Quality statement 4: Blood pressure targets. Published date: March 2013. http://www.nice.org.uk/guidance/QS28/chapter/Quality-statement-4-Blood-pressure-targets. Accessed July 23, 2014.en_US
dc.identifier.citedreferenceDasgupta K, Quinn RR, Zarnke KB, et al. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2014; 30: 485 – 501.en_US
dc.identifier.citedreferenceAmerican Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014; 37 ( suppl 1 ): S14 – S80.en_US
dc.identifier.citedreferenceKidney Disease; Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl. 2012; 2: 337 – 414.en_US
dc.identifier.citedreferenceMattila K, Haavisto M, Rajala S, Heikinheimo R. Blood pressure and five year survival in the very old. Br Med J. 1988; 296: 887 – 889.en_US
dc.identifier.citedreferenceHeikinheimo RJ, Haavisto MV, Kaarela RH, et al. Blood pressure in the very old. J Hypertens. 1990; 8: 361 – 367.en_US
dc.identifier.citedreferenceEgan BM, Zhao Y, Axon RN, et al. Uncontrolled and apparent treatment resistant hypertension in the U.S. 1988–2008. Circulation. 2011; 124: 1046 – 1058.en_US
dc.identifier.citedreferenceDiabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 364: 393 – 403.en_US
dc.identifier.citedreferenceCushman WC, Ford CE, Einhorn PT, et al. Blood pressure control by drug group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2008; 10: 751 – 760.en_US
dc.identifier.citedreferenceThe ACCORD Study Group. Effects of intensive blood‐pressure control in type 2 diabetes mellitus. N Engl J Med. 2010; 362: 1575 – 1585.en_US
dc.identifier.citedreferenceCenters for Disease Control and Prevention. Age‐adjusted hospital discharge rates for nontraumatic lower extremity amputation per 1000 diabetic population by race, United States 1988–2009. http://www.cdc.gov/diabets/statistics/lea/fig6.htm. Accessed September 04, 2014.en_US
dc.identifier.citedreferenceRoyce JM, Hymowitz N, Corbett T. Smoking cessation factors among African Americans and whites. COMMIT Research Group. Am J Public Health. 1993; 83: 220 – 226.en_US
dc.identifier.citedreferenceWeber MA, Bakris GL, Hester A, et al. Systolic blood pressure and cardiovascular outcomes during treatment of hypertension. Am J Med. 2013; 126: 501 – 508.en_US
dc.identifier.citedreferenceMargolis KL, Palermo L, Vittinghoff E, et al. Intensive blood pressure control, falls, and fractures in patients with type 2 diabetes: the ACCORD trial. J Gen Intern Med. 2014; 29: 1599 – 1606.en_US
dc.identifier.citedreferenceTaylor J. The hypertension detection and follow‐up program: a progress report. Circ Res. 1977; 40 ( suppl 1 ): I106 – I109.en_US
dc.identifier.citedreferenceJamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high‐risk patients. N Engl J Med. 2008; 359: 2417 – 2428.en_US
dc.identifier.citedreferenceALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The antihypertensive and lipid‐lowering treatment to prevent heart attack trial major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs. usual care: the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT‐LLT). JAMA. 2002; 288: 2998 – 3007.en_US
dc.identifier.citedreferenceKostis WJ, Cabrera J, Messerli FH, et al. Competing cardiovascular and noncardiovascular risks and longevity in the systolic hypertension in the elderly program. Am J Cardiol. 2014; 113: 676 – 681.en_US
dc.identifier.citedreferenceSaunders E, Shulman N, Hall D. High Blood Pressure in Blacks: Epidemiology, Pathophysiology and Treatment. Chicago, IL: Yearbook Medical Publishers; 1985.en_US
dc.identifier.citedreferenceWilliams RA, Flack JM, Gavin JR III, et al. Guidelines for management of high‐risk African Americans with multiple cardiovascular risk factors: recommendations of an Expert Consensus Panel. Ethn Dis. 2007; 17: 214 – 220.en_US
dc.identifier.citedreferenceFlack JM, Sica DA, Bakris G, et al. Management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks Consensus Statement. Hypertension. 2010; 56: 780 – 800.en_US
dc.identifier.citedreferenceDouglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: a consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003; 163: 525 – 541.en_US
dc.identifier.citedreferenceKearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005; 365: 217 – 223.en_US
dc.identifier.citedreferenceHoward G, Lackland DT, Kleindorfer DO, et al. Racial differences in the impact of elevated systolic blood pressure on stroke risk. JAMA Intern Med. 2013; 173: 46 – 51.en_US
dc.identifier.citedreferenceSelassie A, Wagner CS, Laken ML, et al. Progression is accelerated from pre‐hypertension to hypertension in African Americans. Hypertension. 2011; 58: 579 – 587.en_US
dc.identifier.citedreferenceFerdinand KC, Patterson KP, Taylor C, et al. Community‐based approaches to prevention and management of hypertension and cardiovascular disease. J Clin Hypertens (Greenwich). 2012; 14: 336 – 343.en_US
dc.identifier.citedreferenceHypertension Detection and Follow‐up Program Cooperative Group. Five‐year findings of the hypertension detection and follow‐up program. II. Mortality by race‐sex and age. JAMA. 1979; 242: 2572 – 2577.en_US
dc.identifier.citedreferenceHypertension Detection and Follow‐up Program Cooperative Group. Five‐year findings of the hypertension detection and follow‐up program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA. 1982; 247: 633 – 638.en_US
dc.identifier.citedreferenceLackland DT, Roccella EJ, Deutsch AF, et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke. 2014; 45: 315 – 353.en_US
dc.identifier.citedreferenceEgan BM, Li J, Qanungo S, Wolfman TE. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: a report from NHANES 1988–2010. Circulation. 2013; 128: 29 – 41.en_US
dc.identifier.citedreferenceWright JT Jr, Fine LJ, Lackland DT, et al. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view. Ann Intern Med. 2014; 160: 499 – 504.en_US
dc.identifier.citedreferenceJames PA, Oparil S, Carter BL, et al. 2014 evidence‐based guideline for the management of high blood pressure in adults. Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507 – 520.en_US
dc.identifier.citedreferenceEgan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA. 2010; 303: 2043 – 2050.en_US
dc.identifier.citedreferenceEgan BM, Li J, Shatat IF, et al. Closing the gap in hypertension control between younger and older adults: NHANES 1988 to 2010. Circulation. 2014; 129: 2052 – 2061.en_US
dc.identifier.citedreferenceFields LE, Burt VL, Cutler JA, et al. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004; 44: 398 – 404.en_US
dc.identifier.citedreferenceEgan BM, Zhao Y. Clinical epidemiology of hypertension in the U.S. 1999–2010: different definitions of prevalent hypertension impact the clinical epidemiology of hypertension and attainment of healthy people goals. J Clin Hypertens (Greenwich). 2013; 15: 154 – 161.en_US
dc.identifier.citedreferenceAmerican Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care. 2013; 36 ( suppl 1 ): S11 – S66.en_US
dc.identifier.citedreferenceRose GA, Blackburn H, Gillium RF, Prineas RJ. Cardiovascular Survey Methods, 2nd edn. Geneva, Switzerland: World Health Organization; 1982.en_US
dc.identifier.citedreferenceMuntner P, DeSalvo KB, Wildman RP, et al. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among non‐institutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol. 2006; 163: 913 – 920.en_US
dc.identifier.citedreferenceThe sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157: 2413 – 2446.en_US
dc.identifier.citedreferenceSelvin E, Manzi J, Stevens LA, et al. Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988–1994, 1999–2004. Am J Kidney Dis. 2007; 50: 918 – 926.en_US
dc.identifier.citedreferenceStone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: S1 – S45.en_US
dc.identifier.citedreferenceSHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265: 3255 – 3264.en_US
dc.identifier.citedreferenceStaessen JA, Fagard R, Thijs L, et al. Randomised double‐blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst‐Eur) Trial Investigators. Lancet. 1997; 350: 757 – 764.en_US
dc.identifier.citedreferenceLiu L, Wang JG, Gong L, et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. J Hypertens. 1998; 16: 1823 – 1829.en_US
dc.identifier.citedreferenceWang JG, Staessen JA, Gong L, Liu L; for the Systolic Hypertension in China (Syst‐China) Collaborative Group. Chinese trial on isolated systolic hypertension. Arch Intern Med. 2000; 160: 211 – 220.en_US
dc.identifier.citedreferenceHYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008; 358: 1887 – 1898.en_US
dc.identifier.citedreferenceJATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008; 31: 2115 – 2127.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jch12511.pdf
Size:
312.3KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.